Answer:
Explanation:
Using the dividend growth model = Do(1+g)/Ke-g
Do=1.62$
G=4%
Ke=12%
Do(1+g)/Ke-g = 2.0736(1+4%)/12%-4%
= 1.6848
/8%
= 53.916
Year Year Year Year Year
0 1 2 3 4
20% 20% 20% 20%
Dividend 1 1.2 1.44 1.728 2.0736
Ifninty dividend 55.91*
Total Cashflows 1 1.2 1.44 1.728 55.98
Pres.Val @12% 1 1.07142 1.14795 1.22995 35.583
Value of stock 40.030
Answer:
A
Explanation:
The quality should be about the same.
The social responsibility should also be about the same.
There shouldn't be side effects of most products. If you are speaking of medications, there really ought to be the same side effects with the same severity and the same statistical occurrences.
The only difference is the company selling the product.
There have been exceptions to this where different "fillers" were used in the generic brand and the side effects were different and more severe. I've only heard of one case however and I cannot remember what it was. Manufacturers were careful not to let it happen again.
Answer:
Explanation:
The journal entry is shown below:
On July 1
Treasury stock A/c Dr $5,280
To Cash A/c $5,280
(Being purchase of treasury stock for cash is recorded)
The computation is shown below:
= Number of shares purchased × cash price per share
= 440 shares × $12
= $5,280
All other information which is given is not relevant. Hence, ignored it